Home › Funds › CenterBook Partners LP › BNTX
CenterBook Partners LP position in BNTX
BIONTECH SE · Health Care
CenterBook Partners LP reported holding 251,083 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$23.4M, representing 1.15% of its reported portfolio and ranking #15 among its reported holdings. CenterBook Partners LP has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CenterBook Partners LP's BNTX position evolved
CenterBook Partners LP first disclosed a stake in BNTX in Q2 2024 at 206,234 shares (US$16.6M). The position peaked in Q2 2026 at 251,083 shares, worth US$23.4M. Across 9 filings, CenterBook Partners LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 251,083 shares valued at US$23.4M — an increase of 79,917 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2024 (shares fell 20% over the following quarter), a 97% increase in Q2 2025 (shares fell 7% over the following quarter), a 47% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 206.23K | $16.57M | New |
| Q3 2024 | 119.46K | $14.19M | Reduce |
| Q4 2024 | 194.12K | $22.12M | Add |
| Q1 2025 | 109.42K | $9.96M | Reduce |
| Q2 2025 | 215.94K | $22.99M | Add |
| Q3 2025 | 185.49K | $18.29M | Reduce |
| Q4 2025 | 236.18K | $22.48M | Add |
| Q1 2026 | 171.17K | $15.21M | Reduce |
| Q2 2026 | 251.08K | $23.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 35 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M sh · $140.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on CenterBook Partners LP
FAQ
How long has CenterBook Partners LP held BNTX?
CenterBook Partners LP has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is CenterBook Partners LP's current position in BNTX?
As of Q2 2026, CenterBook Partners LP holds 251.08K shares of BNTX (BIONTECH SE), valued at $23.36M, representing 1.15% of its reported portfolio and ranking #15.
Has CenterBook Partners LP been buying or selling BNTX?
In the latest 13F filing (Q2 2026), CenterBook Partners LP increased its position in BNTX. The position peaked in Q2 2026 at 251.08K shares.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.